Clinical Trial: A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy

U.S., Oct. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07856719) titled 'A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy' on Sept. 29.

Brief Summary: The goal of this clinical research study is to find out if low-dose colchicine (an anti-inflammatory drug) lowers the rate of radiation-related side effects to the carotid artery in patients who have completed radiation therapy for head and neck cancer.

Study Start Date: March 01, 2027

Study Type: INTERVENTIONAL

Condition: Head and Neck Cancer

Intervention: DRUG: Colchicine

0.6 mg given by mouth once daily for 24 months

OTHER: Placebo

Given by mouth once daily for 24 months

Recruitment Status: NOT_YET_RECR...